http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
-
Varian Showcases Radiotherapy Ecosystem at 2019 China Users Meeting
-
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
-
Varian to Present at the J.P. Morgan Healthcare Conference
-
Phoenix Cyberknife and Radiation Oncology Center Delivers Its First HyperArc Treatments
-
Paul Scherrer Institute Utilizing Varian Software Solution for Advanced Proton Therapy Treatments
-
Varian Announces First Quarter Fiscal Year 2019 Earnings Release Date
-
Varian Named One of America's Most Just Companies in 2018 by Forbes and JUST Capital
-
Varian-Equipped Emory Proton Therapy Center Opens
-
Varian Schedules Annual Stockholder Meeting in Palo Alto
-
HollandPTC Opens with ProBeam System from Varian
-
Varian (VAR) Halcyon Treatment System Receives China NMPA Approval
-
Varian Halcyon Treatment System Receives China NMPA Approval
-
MSH Selects Varian Cancer Care Solution to Expand Treatment Capabilities Across South Africa
-
Varian Medical Systems (VAR) Appoints Anat Ashkenazi to Board
-
Anat Ashkenazi Named to Varian Board of Directors
-
Varian to Present at the Citi Global Healthcare Conference
-
Varian Publishes 2018 Sustainability Report
-
Beijing Cancer Hospital Utilizes Varian RapidPlan to Win IDC Digital Transformation Award
-
Varian and GenesisCare to Form Strategic Partnership for Cancer Care Research and Increased Access to Care
-
Varian Reports Results for Fourth Quarter and Full Fiscal Year 2018
-
Varian Ranked First in Probability of Repurchase and Overall Manufacturer, System, and Service Performance in 2018 Survey of Radiation Oncology Professionals
-
Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite
-
Varian Unveils New Bravos Afterloader System for Brachytherapy Treatments
-
Varian Forms FlashForward Consortium to Study Ultra-high Dose Rate Cancer Treatments with Protons
-
Varian Introduces New ProBeam 360° Proton Therapy System
-
Varian Medical Systems (VAR) announced acquisition of Noona Healthcare
-
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
-
Varian Medical Systems (VAR) Announces Educational Partnerships with Reliance Group in India
-
Varian Signs Educational Partnerships with Reliance Group in India
-
Varian Appoints New Division Presidents
-
Sterling Cancer Hospital Treats First Patient in India on Varian Halcyon System
-
Varian Shares Vision of a World Without Fear of Cancer
-
Varian Medical Systems (VAR) Appoints Dr. Jeff Balser to Board
-
Dr. Jeff Balser Named to Varian Board of Directors
-
Epic Sciences Announces Completion of $52 Million Series E Financing
-
Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya
-
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
-
Varian to Present at Baird Global Healthcare Conference
-
Varian Announces Fourth Quarter Fiscal Year 2018 Earnings Release Date and Upcoming Investor Meeting at ASTRO
-
Varian CEO Dow Wilson Joins USISPF Board of Directors
-
Varian Medical Systems (VAR) Buys humediQ Global GmbH
-
Varian Announces Acquisition of humediQ Global GmbH
-
Varian Reports Results for Third Quarter of Fiscal Year 2018
-
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
-
Varian Installs ProBeam Cyclotron at UCLH Proton Beam Therapy Center
-
Varian Medical Systems (VAR) Informed Sirtex that it Will not be Providing Counter Proposal to CDH-CGP Offer
-
Varian Provides Update on Proposed Sirtex Acquisition
-
Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date
-
Varian to Demonstrate Advanced Brachytherapy Solutions at ABS 2018

